COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

MLA

Giuseppina Massini, et al. “Combined Modality Treatment Including Methotrexate-Based Chemotherapy for Primary Cerebral Nervous System Lymphoma: A Single Institution Experience.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 1, no. 2, Nov. 2009, p. e2009020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.506f4d2c003143ffb8213a539d6da5b5&authtype=sso&custid=ns315887.

APA

Giuseppina Massini, Francesco D’Alo’, Angelo Pompucci, Stefania Manfrida, Mario Balducci, Luciana Teofili, Stefan Hohaus, Luigi Maria Larocca, Roberto Marra, & Sergio Storti. (2009). Combined Modality Treatment Including Methotrexate-Based Chemotherapy for Primary Cerebral Nervous System Lymphoma: A Single Institution Experience. Mediterranean Journal of Hematology and Infectious Diseases, 1(2), e2009020.

Chicago

Giuseppina Massini, Francesco D’Alo’, Angelo Pompucci, Stefania Manfrida, Mario Balducci, Luciana Teofili, Stefan Hohaus, Luigi Maria Larocca, Roberto Marra, and Sergio Storti. 2009. “Combined Modality Treatment Including Methotrexate-Based Chemotherapy for Primary Cerebral Nervous System Lymphoma: A Single Institution Experience.” Mediterranean Journal of Hematology and Infectious Diseases 1 (2): e2009020. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.506f4d2c003143ffb8213a539d6da5b5&authtype=sso&custid=ns315887.